NB Perspectives to Ongoing Regulatory Change
Caroline Dore Geraghty of National Standards Authority of Ireland is a distinguished presenter participating at the Q1 Productions EU Medical Device Post Market Clinical Evaluation Planning Conference this October 29-30 in Frankfurt, Germany. Geraghty along with many other medical device industry experts and notified body speakers will cover timely challenges and crucial topics within the industry. Read on to learn more about her role and what attendees can expect from her session.
Can you please give a brief description of your title and what that entails?
I am the director of medical devices for the National Standards Authority of Ireland, which in turn means I am the head of the notified body, previously I was the chief clinical evaluator for NSAI.
Please share a short overview of the panel you’ll be participating in, “Notified Bodies’ Interpretation of MDR-Compliant Post-Market Requirements.”
I will be participating in a panel discussing the post market requirements of the MDR, it will give a unique insight into the notified body interpretation of the requirements.
What do you hope participants will learn from the panel?
Hopefully there will be active discussion on the interpretations, and the attendees will understand the requirements and the implementation of the requirements.
Why do you think it’s important for clinical affairs professionals to attend the EU Medical Device Post-Market Clinical Evaluation Planning Conference?
There is so much regulatory change going on at the moment it is essential that all actors in the system have open and frank discussions about the MDR requirements so that there is a level playing field for all involved.
Don’t miss this interactive conversation and many other topics on gathering post-market clinical follow-up data, cost-effective data collection and more. Save your spot at the EU Medical Device Post Market Clinical Evaluation Planning Conference today.